Human Primary Tumorgraft Models: Comparisons with Traditional Oncology Pre-Clinical Models and The Clinical Relevance and Utility of Primary Tumorgrafts in Basic and Translational Oncology Research

نویسندگان

  • David H. Lum
  • Cindy Matsen
  • Alana L. Welm
  • Bryan E. Welm
چکیده

Laboratory models that accurately replicate human tumors are integral to cancer research. However, comparative studies between commonly employed laboratory models and human tumors have demonstrated that some models have molecular and genomic alterations dissimilar to the cancer type they attempt to replicate. In contrast, several recent comparative studies suggest that patient-derived tumors grown in mice maintain many of the important characteristics of the original tumor and represent an important tool for the development of new cancer therapeutics. Many models are now available for mechanistic and therapeutic research, and each system has both strengths and weakness. This review will discuss the advantages and disadvantages of the most commonly used models of cancer and highlight advances in the generation and use of patient-derived tumorgrafts.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma.

Most anticancer drugs entering clinical trials fail to achieve approval from the U.S. Food and Drug Administration. Drug development is hampered by the lack of preclinical models with therapeutic predictive value. Herein, we report the development and validation of a tumorgraft model of renal cell carcinoma (RCC) and its application to the evaluation of an experimental drug. Tumor samples from ...

متن کامل

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

PURPOSE Ovarian cancer has a high recurrence and mortality rate. A barrier to improved outcomes includes a lack of accurate models for preclinical testing of novel therapeutics. EXPERIMENTAL DESIGN Clinically relevant, patient-derived tumorgraft models were generated from sequential patients and the first 168 engrafted models are described. Fresh ovarian, primary peritoneal, and fallopian tub...

متن کامل

Development and Histopathological Characterization of Tumorgraft Models of Pancreatic Ductal Adenocarcinoma

Pancreatic cancer is the one of the deadliest of all malignancies. The five year survival rate for patients with this disease is 3-5%. Thus, there is a compelling need for novel therapeutic strategies to improve the clinical outcome for patients with pancreatic cancer.  Several groups have demonstrated for other types of solid tumors that early passage human tumor xenograft models can be used t...

متن کامل

From human to mouse and back: 'tumorgraft' models surge in popularity.

resistance to gemcitabine, the standard therapy for pancreatic cancer, and sensitivity to mitomycin C, a rarely used treatment. The patient — who fi rst failed gemcitabine therapy — received mitomycin C and has been in remission for more than 2 years. The trial’s principal investigator, Manuel Hidalgo , M.D., Ph.D., stressed that tumorgrafts, at present, can be of only limited use for individua...

متن کامل

Cancer Therapy: Preclinical Tumorgrafts as In Vivo Surrogates for Women with Ovarian Cancer

Purpose: Ovarian cancer has a high recurrence and mortality rate. A barrier to improved outcomes includes a lack of accurate models for preclinical testing of novel therapeutics. Experimental Design: Clinically relevant, patient-derived tumorgraft models were generated from sequential patients and the first 168 engrafted models are described. Fresh ovarian, primary peritoneal, and fallopian tub...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2013